MM+M Podcast 8.2.22: Could biopharma M&A ramp up in the second half?

There are strong underlying reasons to suggest a return to large-scale - potentially even transformative - M&A in the coming months. Subin Baral, global life sciences deals leader at EY, shares his research-based predictions for where biopharma dealmaking could be headed in the second half. Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in
medical marketing, subscribe here.
Music: “Deep Reflection” by DP and Triple Scoop Music.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.